S 2039
Cancer Drug Parity Act of 2023
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Cancer Drug Parity Act of 2023 aims to ensure that people with cancer pay the same cost-sharing amounts for oral anticancer drugs as they do for similar drugs administered by a healthcare provider. This bill requires group health plans to treat oral anticancer medications with the same cost-sharing rules as intravenously administered or injected medications, provided they meet specific medical criteria. It also restricts plans from making changes that would increase out-of-pocket costs for these medications and includes a study to assess the impact of the law on patient access and affordability.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Angus S., Jr. King
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.